Genetically engineered pre-microRNA-34a prodrug suppresses orthotopic osteosarcoma xenograft tumor growth via the induction of apoptosis and cell cycle arrest
Yong Zhao(Wuhan University), Ai‐Ming Yu(University at Buffalo, State University of New York)
Cited by 43
Related Papers
Bioengineered Noncoding RNAs Selectively Change Cellular miRNome Profiles for Cancer Therapy
|Journal of Pharmacology and Experimental Therapeutics|2018|68
Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells
|Drug Metabolism and Disposition|2017|62